期刊文献+

离子色谱法测定阿洛西林钠中钠离子含量与成盐率考察 被引量:3

Determination of Sodium Ion and Salt-forming Rate in Azlocillin Sodium by Ion Chromatography
下载PDF
导出
摘要 目的建立离子色谱法测定阿洛西林钠中钠离子含量,通过考察不同企业样品的成盐率,对该品种的成盐工艺质量控制进行评价。方法采用IonPac CS-12A阳离子交换色谱柱(4×250 mm)和IonPac CG-12A保护柱(4×50 mm),20 mmol·L^(-1)甲烷磺酸溶液为流动相,流速1.0 mL·min^(-1),抑制器电流为65mA。结果钠离子在浓度5~15μg·mL^(-1)范围内与峰面积呈良好的线性关系,r=0.9999(n=5),平均回收率为102.9%(RSD=2.1%,n=9),测定九个厂家共100批注射用阿洛西林钠的成盐率均在97.9%~107.0%之间。结论本方法可用于阿洛西林钠的钠离子测定,各企业产品的成盐率工艺控制较稳定。 OBJECTIVE To establish an ion chromatographic method to determine the content of sodium ion and salt-forming rate in Azlocillin Sodium.According to the method,the salt formation process of different enterprises were evaluated.METHODS A column of IonPac CS-12A(4×250 mm)and a protect column of IonPac CG-12A(4×50 mm)were used.20 mmol·L^(-1)of MSA solution as the mobile phase.The flow rate was 1.0 mL·min^(-1) and the suppressor current value was set as 65 mA.RESULTS The linear range was 5-15μg·mL^(-1),r=0.9999(n=5),the average recovery rate was 102.9%(RSD=2.1%,n=9).The salt-forming rate of 100 batches of Azlocillin sodium for injection provided by nine manufacturers were between 97.9%-107.0%.CONCLUSION This method can be used for the sodium ion determination of Azlocillin sodium,and the process control of the salt-formation rate of the products of various enterprises is relatively stable.
作者 陈茜 伍雯琦 高丹玲 CHEN Qian;WU Wen-qi;GAO Dan-ling(Fujian Institute for Food and Drug Quality Control,Fuzhou 350001,China)
出处 《海峡药学》 2021年第11期77-80,共4页 Strait Pharmaceutical Journal
关键词 离子色谱 电导检测器 阿洛西林钠 钠离子 成盐率 Ionchromatography Conductivity detector Azlocillin Sodium Sodium ion Salt-forming rate
  • 相关文献

参考文献4

二级参考文献40

  • 1熊建华,王淑君.正交法考查阿洛西林钠在输液中的稳定性[J].天津药学,2005,17(4):24-26. 被引量:6
  • 2叶建林,殷建忠.阿洛西林钠与10%葡萄糖注射液配伍产生混浊原因探讨[J].临床和实验医学杂志,2007,6(4):105-105. 被引量:14
  • 3何海涛.CDR用药手册[M].北京:中国国际出版社,2008:460.
  • 4朱江,张吉菲,陈丽华.我院186例药品不良反应报告分析[J].中国临床药学杂志,2007,16(5):324-325. 被引量:5
  • 5Wermuth C G. The Practice of Medicinal Chemistry[M].Boston:academic Press,2008.749-766.
  • 6Paulekuhn G S,Dressman J B,Saal C. Trends in active pharmaceutical ingredient salt selection based on analysis of the orange book database[J].Journal of Medicinal Chemistry,2007,(26):6665-6672.doi:10.1021/jm701032y.
  • 7Tao T,Zhao Y,Wu J J. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement[J].International Journal of Pharmaceutics,2009,(1/2):109-114.doi:10.1016/j.ijpharm.2008.09.034.
  • 8Ware E C,Lu D R. An automated approach to salt selection for new unique trazodone salts[J].Pharmaceutical Research,2004,(01):177-184.doi:10.1023/B:PHAM.0000012167.60180.c3.
  • 9Han H K,Choi H K. Improved absorption of meloxicam via salt formation with ethanolamines[J].European Journal of Pharmaceutics and Biopharmaceutics,2007,(01):99-103.doi:10.1016/j.ejpb.2006.07.003.
  • 10Gwak H S,Choi J S,Choi H K. Enhanced bioavailability of piroxicam via salt formation with ethanolamines[J].International Journal of Pharmaceutics,2005,(1/2):156-161.doi:10.1016/j.socscimed.2011.08.005.

共引文献34

同被引文献48

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部